📈MIAX Pearl Proposes Rule Change for PAC Routing Options
The MIAX PEARL, LLC proposes an amendment to Exchange Rule 2617 to enhance the PAC routing option by eliminating unnecessary specification of primary listing markets. This change aims to simplify regulatory compliance, ensuring relevant practices remain dynamic and accurate as the number of primary listing markets evolves, benefiting equity market participants.
Learn More🧬NIH Notice of Closed Meetings for Grant Applications
The Department of Health and Human Services announced closed meetings for the Center for Scientific Review to evaluate grant applications in various scientific fields. The meetings aim to maintain confidentiality concerning sensitive information related to grant discussions and are crucial for businesses seeking financial support in health-related research and technology development.
Learn More⚓Impact of Security Zone Removal in Old Tampa Bay
The Coast Guard is disestablishing a security zone in old Tampa Bay, including on land portions of Chemical Formulators Chlorine Facility. The security zone is no longer needed since Chemical Formulators facility is no longer operating. This action will remove existing regulations that restrict vessel movement through the area.
Learn More💰Sequestration Order for Fiscal Year 2026
This document outlines a sequestration order issued by the President, mandating reductions to direct spending budgetary resources for fiscal year 2026. It specifies compliance protocols under the Balanced Budget and Emergency Deficit Control Act, indicating a significant measure to control federal expenditures and its implications on budget allocations across various sectors.
Learn More📋FDA Releases Guidance on Raw Data Submission for Animal Drugs
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry (GFI) #287 entitled "Raw Data for Safety and Effectiveness Studies." This guidance provides information to animal drug sponsors (sponsors) on the use of raw data in the Center for Veterinary Medicine's (CVM) review of safety and effectiveness studies submitted in support of new animal drug applications. This guidance also describes our recommendations for submitting raw data.
Learn More🧬Amended Meeting Notice for National Human Genome Research Institute
The notice announces a change in the meeting schedule for the National Advisory Council for Human Genome Research from a two-day to a one-day format. The meeting will now take place in person and virtually, allowing for broader attendance and participation. The notice includes the adjusted timing and a link for virtual attendance.
Learn More🎆Coast Guard Safety Zone Regulation for Bayfield Fireworks
The Coast Guard will enforce a safety zone for the City of Bayfield 4th of July Fireworks Display in Bayfield, WI. This action is intended to protect personnel, vessels, and the marine environment from potential hazards created by a fireworks display. During the enforcement period listed below, entry into, transiting, or anchoring within the safety zone is prohibited unless authorized by the Captain of the Port (COTP) Marine Safety Unit Duluth or his or her on-scene representative.
Learn More⚖️Antidumping Duty Review Results for Stainless Steel Flanges from India
The U.S. Department of Commerce (Commerce) finds that producers/exporters of stainless steel flanges (flanges) from India subject to this administrative review made sales of subject merchandise in the United States at prices below normal value during the period of review (POR) October 1, 2022, through September 30, 2023.
Learn More📈ICC Approval of New Governance Playbook Enhances Risk Management
The SEC approved a proposed rule change by ICE Clear Credit LLC to revise its Governance Playbook. This includes establishing a Board Risk Committee responsible for overseeing risk management and implementing new fitness standards for board members, thus enhancing governance and compliance within the organization.
Learn More📄FDA Draft Guidance on 510(k) Clearance Transfer Available
The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Transfer of a Premarket Notification (510(k)) Clearance--Questions and Answers." This guidance provides information on the most frequently asked questions regarding transfer of ownership from one 510(k) holder to another. This draft guidance is not final nor is it for implementation at this time.
Learn More